These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18046980)

  • 41. Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: III. Lack of association of CYP3A4 and CYP2D6 gene polymorphisms.
    Tiwari AK; Deshpande SN; Rao AR; Bhatia T; Lerer B; Nimgaonkar VL; Thelma BK
    Schizophr Res; 2005 Jun; 75(1):21-6. PubMed ID: 15820320
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetic parameters of bromperidol in Korean subjects.
    Lee SY; Kim YG; Kim HG; Kim JW
    Hum Psychopharmacol; 2006 Aug; 21(6):409-12. PubMed ID: 16915578
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The consequences of 3,4-methylenedioxymethamphetamine induced CYP2D6 inhibition in humans.
    O'Mathúna B; Farré M; Rostami-Hodjegan A; Yang J; Cuyàs E; Torrens M; Pardo R; Abanades S; Maluf S; Tucker GT; de la Torre R
    J Clin Psychopharmacol; 2008 Oct; 28(5):523-9. PubMed ID: 18794647
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Importance of genetic polymorphism of cytochrome P450 isoenzymes for the choice and regimes of antidepressant and antipsychotic dosing on an individual basis].
    Savel'eva MI; Sychev DA; Kazakov RE; Ignat'ev IV; Tishenova A; Gasanov NA; Ramenskaia GV; Kukes VG
    Klin Med (Mosk); 2008; 86(11):22-8. PubMed ID: 19177788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction.
    Rebsamen MC; Desmeules J; Daali Y; Chiappe A; Diemand A; Rey C; Chabert J; Dayer P; Hochstrasser D; Rossier MF
    Pharmacogenomics J; 2009 Feb; 9(1):34-41. PubMed ID: 18591960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Failure to respond to treatment with typical antipsychotics is not associated with CYP2D6 ultrarapid hydroxylation.
    Aitchison KJ; Munro J; Wright P; Smith S; Makoff AJ; Sachse C; Sham PC; Murray RM; Collier DA; Kerwin RW
    Br J Clin Pharmacol; 1999 Sep; 48(3):388-94. PubMed ID: 10510151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Personalized antipsychotic treatment: the adverse effects perspectives.
    Plesnicar BK
    Psychiatr Danub; 2010 Jun; 22(2):329-34. PubMed ID: 20562775
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathway-based association analysis of genome-wide screening data suggest that genes associated with the gamma-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia.
    Inada T; Koga M; Ishiguro H; Horiuchi Y; Syu A; Yoshio T; Takahashi N; Ozaki N; Arinami T
    Pharmacogenet Genomics; 2008 Apr; 18(4):317-23. PubMed ID: 18334916
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impaired tamoxifen metabolism reduces survival in familial breast cancer patients.
    Newman WG; Hadfield KD; Latif A; Roberts SA; Shenton A; McHague C; Lalloo F; Howell S; Evans DG
    Clin Cancer Res; 2008 Sep; 14(18):5913-8. PubMed ID: 18794105
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antipsychotic-induced movement disorders - forgotten but not gone.
    Weiden PJ
    Acta Psychiatr Scand; 2008 Jun; 117(6):401-2. PubMed ID: 18479315
    [No Abstract]   [Full Text] [Related]  

  • 51. Proof of a 1-(3-chlorophenyl)piperazine (mCPP) intake: use as adulterant of cocaine resulting in drug-drug interactions?
    Staack RF; Paul LD; Schmid D; Roider G; Rolf B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(2):127-33. PubMed ID: 17574934
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of CYP2D6*2 and CYP2D6*4 alleles on phenotype in polymedicated depressed inpatients: therapeutic consequences?
    Haffen E; Vandel P; Paintaud G; Broly F; Vandel S; Bonin B; Bizouard P; Sechter D; Bechtel PR
    Eur J Clin Pharmacol; 2000; 55(11-12):877-9. PubMed ID: 10805068
    [No Abstract]   [Full Text] [Related]  

  • 53. Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or/and duplication of the CYP2D6 gene.
    Arneth B; Shams M; Hiemke C; Härtter S
    Clin Biochem; 2009 Aug; 42(12):1282-90. PubMed ID: 19393232
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo microdialysis studies of striatal level of neurotransmitters after haloperidol and chlorpromazine administration.
    Kulkarni SK; Bishnoi M; Chopra K
    Indian J Exp Biol; 2009 Feb; 47(2):91-7. PubMed ID: 19374163
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increase in the risk of chlorpromazine-induced QT prolongation during nighttime: is a short-period ECG during daytime sufficient?
    Suzuki Y; Watanabe J; Ono S; Fukui N; Sugai T; Tsuneyama N; Someya T
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1122-3. PubMed ID: 20394793
    [No Abstract]   [Full Text] [Related]  

  • 56. CYP2D6 and DRD2 genes differentially impact pharmacodynamic sensitivity and time course of prolactin response to perphenazine.
    Aklillu E; Kalow W; Endrenyi L; Harper P; Miura J; Ozdemir V
    Pharmacogenet Genomics; 2007 Nov; 17(11):989-93. PubMed ID: 18075468
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Developmental changes in human liver CYP2D6 expression.
    Stevens JC; Marsh SA; Zaya MJ; Regina KJ; Divakaran K; Le M; Hines RN
    Drug Metab Dispos; 2008 Aug; 36(8):1587-93. PubMed ID: 18474679
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phenothiazine poisoning. A review of 48 cases.
    Barry D; Meyskens FL; Becker CE
    Calif Med; 1973 Jan; 118(1):1-5. PubMed ID: 4405537
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pharmacogenetics of antipsychotics in schizophrenia].
    Méary A
    Therapie; 2008; 63(3):243-6. PubMed ID: 18718213
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ABCB1 and CYP2D6 polymorphisms and treatment response of psychotic patients in a naturalistic setting.
    Papazisis G; Goulas A; Sarrigiannidis A; Bargiota S; Antoniadis D; Raikos N; Basgiouraki E; Bozikas VP; Garyfallos G
    Hum Psychopharmacol; 2018 Jan; 33(1):. PubMed ID: 29250824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.